News Aug 23, 2023 Sion’s Pôle Santé takes shape with the laying of the first stone Valued at CHF 86 million, the Pôle Santé campus aims to be a platform for the exchange of knowledge, experience and opportunities in the healthca...
Commercial HQ in Switzerl... May 09, 2023 Commercial HQ in Switzerland Setting up Your Commercial HQ in Switzerland: The Key to European Market Success: Are you a pharmaceutical company seeking to access the European...
News Oct 16, 2023 Adiposs completes the phase I clinical trial of its flagship product ImageBAT Geneva-based biotech Adiposs casts a ray of hope onto the horizons of cancer treatment and patient care with the successful conclusion of the Pha...
News Aug 14, 2023 Bern’s thriving ecosystem for life sciences innovation In the heart of Western Switzerland, the canton of Bern has emerged as a location of choice for companies in the life sciences sector.
Innovation Jul 11, 2023 Locate Investors Discover how you can benefit from Switzerland's strong investor base and several accelerator programs to support the launch and growth of your li...
News Apr 05, 2023 HealthMe Technologies thrives in Valais’ digital health ecosystem Valais-based start-up HealthMe Technologies has been making waves recently after being selected for the CSS and EPFL’s Future of Health Grant pro...
Spotlight Jun 15, 2023 Access to Ecosystem Switzerland is a global leader in biotech, medtech and pharma. Find out what makes the Swiss life science industry unique and how your life scien...
News Feb 28, 2023 Terapet raises CHF 2.3 million for its next-generation cancer treatment technology Geneva-based medtech Terapet has announced the closing of its first Pre-Series A investment round in the amount of CHF 2.3 million.
News Jun 19, 2023 Revolutionary breakthrough in prostate cancer treatment at the University of Bern In an exciting turn of events in the world of cancer therapy, researchers from the University of Bern, Inselspital Bern, and the University of Co...
News Apr 11, 2023 CSEM has developed a 3D printed medical cushion for wheelchair users CSEM has joined forces with the Swiss Paraplegic Foundation (SPS) to develop a custom 3D-printed medical-grade cushion for wheelchair users.
News Feb 01, 2022 Merck acquires Geneva-based biopharmaceutical company Chord Therapeutics Chord Therapeutics, a clinical stage biopharmaceutical company developing drugs for rare neuroinflammatory diseases, is being acquired by Merck.
News Aug 10, 2021 Women’s health biopharmaceutical company ObsEva receives USD 500 million ObsEva, a Geneva-based biopharmaceutical company dedicated to improving women’s reproductive health, will receive up to USD 500 million for the l...
Actualités Jul 12, 2023 Bearmind, Diatheris et Zizania se hissent au sommet des prix >>venture>> 2023 Les prestigieux prix >>venture>>, le principal concours de start-ups en Suisse, ont récompensé des start-ups de Suisse occidentale : Bearmind, Di...
News Nov 29, 2022 CHUV, CERN and THERYQ join forces for a world first in cancer radiotherapy CHUV, CERN and THERYQ will develop a revolutionary FLASH radiotherapy device to treat cancers resistant to conventional treatments.
News May 03, 2022 Why Switzerland’s pioneering role in blockchain combined with its biotech heritage makes it a source of innovation With the rise of new technologies such as blockchain and AI, the pragmatic regulatory approach of the Swiss authorities has become an important a...